Oculis Holding AG (OCS)
(Delayed Data from NSDQ)
$12.20 USD
+0.11 (0.91%)
Updated Oct 2, 2024 12:20 PM ET
After-Market: $12.20 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Oculis Holding AG falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 1 | 1 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 1 | 1 | 1 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 91 | 35 | 16 | 0 | 0 |
Income After Depreciation & Amortization | -90 | -34 | -14 | 0 | 0 |
Non-Operating Income | -7 | 0 | 0 | NA | NA |
Interest Expense | 1 | 7 | 6 | NA | NA |
Pretax Income | -99 | -40 | -20 | NA | NA |
Income Taxes | 0 | 0 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -99 | -41 | -20 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -99 | -41 | -20 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -90 | -34 | -14 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | NA | NA |
Income After Depreciation & Amortization | -90 | -34 | -14 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.86 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.82 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -3.31 | -13.56 | -7.31 | NA | NA |
Fiscal Year end for Oculis Holding AG falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 0.27 | 0.25 | 0.21 | 0.25 | 0.28 |
Cost Of Goods | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Gross Profit | 0.27 | 0.25 | NA | 0.25 | 0.28 |
SG&A, R&D, and Dept/Amort Expenses | 25.14 | 17.78 | 0.00 | 14.91 | 12.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | -24.87 | -17.53 | 0.00 | -14.66 | -11.95 |
Non-Operating Income | 1.95 | -0.79 | NA | -5.16 | -2.23 |
Interest Expense | 0.10 | 0.05 | NA | 0.01 | 0.02 |
Pretax Income | -23.01 | -18.36 | NA | -19.84 | -14.20 |
Income Taxes | 0.03 | 0.03 | NA | -0.13 | 0.13 |
Minority Interest | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Income From Cont. Operations | -23.04 | -18.40 | -14.11 | -19.71 | -14.32 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -23.04 | -18.40 | -14.11 | -19.71 | -14.32 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 40.86 | 36.62 | 36.76 | 36.33 | 33.89 |
Diluted EPS Before Non-Recurring Items | -0.56 | -0.44 | -0.38 | -0.38 | -0.42 |
Diluted Net EPS (GAAP) | -0.56 | -0.50 | -0.38 | -0.54 | -0.42 |